Don't miss

Replay


LATEST SHOWS

FRANCE IN FOCUS

French education: Reinventing the idea of school

Read more

FRENCH CONNECTIONS

Frogs legs and brains? The French food hard to stomach

Read more

#TECH 24

Station F: Putting Paris on the global tech map

Read more

THE INTERVIEW

Davos 2017: 'I believe in the power of entrepreneurs to change the world'

Read more

#THE 51%

Equality in the boardroom: French law requires large firms to have 40% women on boards

Read more

FASHION

Men's fashion: Winter 2017/2018 collections shake up gender barriers

Read more

ENCORE!

Turkish writer Aslı Erdoğan speaks out about her time behind bars

Read more

REVISITED

Video: Threat of economic crisis still looms in Zimbabwe

Read more

BUSINESS DAILY

DAVOS 2017: Has the bubble burst?

Read more

Business

China probes France’s Sanofi for bribery

© AFP

Text by FRANCE 24

Latest update : 2013-08-11

French drugmaker Sanofi has been accused of dishing out almost $280,000 in bribes to Chinese doctors in 2007 in a bid to up its sales. Beijing corruption officials have opened a formal investigation.

French drugmaker Sanofi has been accused of dishing out almost $280,000 in bribes to Chinese doctors in 2007 in a bid to up its sales. Beijing corruption officials have opened a formal investigation, and Sanofi says it is taking the allegations very seriously.

The investigation, to be carried out by Beijing city health and corruption officials, was launched in response to claims by an unnamed whistleblower that the French company had paid 503 doctors a total of $274,000 to prescribe Sanofi products.

Sanofi said in a statement it was aware of the report but it said it was premature to comment on events that may have occurred in 2007.

However, it also stated that it took the allegations "very seriously", and as a company had zero tolerance for any unethical practices.

Payments to medical staff

The whilstleblower told the Guangzhou based, state owned, 21st Century Business Herald newspaper that in 2007 Sanofi paid doctors 80 yuan ($13) every time a patient bought its products, with the largest payment being 11,200 yuan.

Most of the payments were reportedly made to medical staff in hospitals in Beijing, the commercial hub of Shanghai, the southern city of Guangzhou and the eastern city of Hangzhou. The payments were disguised as grants for research programmes, the whilstleblower report claimed.

A spokesman told state news agency Xinhua that the Beijing municipal health bureau will coordinate with the disciplinary authorities to investigate the case.

The Sanofi allegations come after four executives from British drug firm GlaxoSmithKline (GSK) were arrested last month for alleged bribery and other offences. Chinese police detained the GSK executives on charges that they had funnelled up to 3 billion yuan ($489 million) to travel agencies to facilitate bribes to doctors and officials.

China's top economic planner is currently investigating 60 foreign and domestic pharmaceutical companies operating in China on similar grounds.

(FRANCE 24 with wires)

Date created : 2013-08-10

  • PHARMACEUTICAL INDUSTRY

    French giant Sanofi-Aventis bids 14.5 billion euros for US biotech firm Genzyme

    Read more

COMMENT(S)